Ondine Biomedical, Inc. (GB:OBI) has released an update.
Ondine Biomedical Inc. is set to release its audited results for 2023 on June 7, 2024, followed by a live presentation for investors on June 10. The event will allow shareholders to engage with the company’s President and CTO, Dr. Nicolas Loebel, and ask questions. The company, known for its innovative photodisinfection therapies, will also hold its 2024 Annual General Meeting virtually on June 28.
For further insights into GB:OBI stock, check out TipRanks’ Stock Analysis page.
